GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Blackrock Health Sciences Trust (NYSE:BME) » Definitions » Capex-to-Operating-Cash-Flow

Blackrock Health Sciences Trust (Blackrock Health Sciences Trust) Capex-to-Operating-Cash-Flow : 0.00 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Blackrock Health Sciences Trust Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Blackrock Health Sciences Trust's Capital Expenditure for the six months ended in Dec. 2023 was $0.00 Mil. Its Cash Flow from Operations for the six months ended in Dec. 2023 was $18.03 Mil.

Hence, Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow for the six months ended in Dec. 2023 was 0.00.


Blackrock Health Sciences Trust Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blackrock Health Sciences Trust Capex-to-Operating-Cash-Flow Chart

Blackrock Health Sciences Trust Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial - - - - -

Blackrock Health Sciences Trust Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow

For the Asset Management subindustry, Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow falls into.



Blackrock Health Sciences Trust Capex-to-Operating-Cash-Flow Calculation

Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / 32.019
=0.00

Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / 18.026
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blackrock Health Sciences Trust  (NYSE:BME) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Blackrock Health Sciences Trust Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Blackrock Health Sciences Trust's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Blackrock Health Sciences Trust (Blackrock Health Sciences Trust) Business Description

Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
Executives
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Kyle Mcclements other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
H Erin Xie other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Catherine A. Lynch director 55 EAST 52ND STREET, NEW YORK NY 10055
Jonathan Diorio officer: Vice President 55 EAST 52ND STREET, NEW YORK NY 10055